
The Clorox Company (NYSE:CLX – Free Report) – Investment analysts at Zacks Research reduced their Q3 2026 earnings per share (EPS) estimates for shares of Clorox in a report released on Tuesday, February 17th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.48 per share for the quarter, down from their prior forecast of $1.55. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q4 2026 earnings at $2.23 EPS, Q2 2027 earnings at $1.56 EPS, Q3 2027 earnings at $1.56 EPS, FY2027 earnings at $6.74 EPS and Q2 2028 earnings at $1.69 EPS.
Other analysts also recently issued reports about the company. Citigroup upped their price objective on Clorox from $109.00 to $115.00 and gave the company a “neutral” rating in a research note on Wednesday, February 4th. Royal Bank Of Canada set a $132.00 price objective on shares of Clorox in a research note on Wednesday, February 4th. Barclays reiterated an “underweight” rating and set a $109.00 price target on shares of Clorox in a report on Friday, January 16th. The Goldman Sachs Group reduced their target price on Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research report on Wednesday, January 7th. Finally, BNP Paribas Exane raised shares of Clorox from an “underperform” rating to a “neutral” rating in a research note on Wednesday, February 11th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $118.73.
Clorox Stock Performance
NYSE:CLX opened at $122.04 on Thursday. Clorox has a fifty-two week low of $96.66 and a fifty-two week high of $159.04. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The company has a 50 day moving average price of $109.36 and a 200 day moving average price of $113.68. The stock has a market capitalization of $14.76 billion, a P/E ratio of 19.94, a PEG ratio of 0.61 and a beta of 0.59.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the business earned $1.55 EPS. The company’s quarterly revenue was down .8% on a year-over-year basis.
Institutional Investors Weigh In On Clorox
Several hedge funds have recently added to or reduced their stakes in CLX. Haverford Trust Co lifted its stake in Clorox by 2.8% in the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares during the last quarter. Savvy Advisors Inc. boosted its position in shares of Clorox by 1.4% in the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after acquiring an additional 91 shares during the period. Canandaigua National Bank & Trust Co. increased its holdings in Clorox by 0.8% during the 3rd quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after acquiring an additional 94 shares during the period. State of Michigan Retirement System lifted its stake in Clorox by 0.3% in the 2nd quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after purchasing an additional 100 shares in the last quarter. Finally, Field & Main Bank boosted its holdings in Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock valued at $313,000 after purchasing an additional 100 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Key Clorox News
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Clorox published a consumer research report, “Home Care Redefined,” highlighting shifting demand toward wellness‑focused and convenience‑oriented home care — a narrative that supports Clorox’s premium, innovation and marketing strategies and could help sustain pricing/brand strength. Home Care Redefined
- Neutral Sentiment: Management presented prepared remarks at the Consumer Analyst Group of New York (CAGNY) conference; these presentations typically reiterate strategy and portfolio priorities but rarely change near‑term financials unless new guidance is provided. Investors will be watching for Q&A takeaways on cost savings, innovation cadence and margin recovery. CAGNY Prepared Remarks Transcript
- Neutral Sentiment: Wells Fargo reiterated a Hold on CLX (coverage note flagged in recent press), which is unlikely to trigger strong buying momentum; it keeps analyst sentiment around the stock cautious. Wells Fargo Hold
- Negative Sentiment: Zacks Research cut multiple near‑term EPS estimates (several quarters and FY2027 modestly lowered) and kept a “Hold” rating. The downward revisions signal weaker near‑term profit expectations and are the most direct driver of selling pressure today. (Source: Zacks research notes summarized across recent releases.)
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Articles
- Five stocks we like better than Clorox
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- Gilder: Don’t Buy AI Stocks, Do This Instead
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
